
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
Luigia Stefania Stucci, Valeria Internò, Marco Tucci, et al.
Genes (2021) Vol. 12, Iss. 5, pp. 727-727
Open Access | Times Cited: 69
Luigia Stefania Stucci, Valeria Internò, Marco Tucci, et al.
Genes (2021) Vol. 12, Iss. 5, pp. 727-727
Open Access | Times Cited: 69
Showing 1-25 of 69 citing articles:
Biomarkers in Breast Cancer: An Old Story with a New End
Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 50
Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 50
Cancer, metastasis, and the epigenome
Saurav Kiri, Tyrone Ryba
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Saurav Kiri, Tyrone Ryba
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
Eva Kúdelová, Marek Smolár, Veronika Holubeková, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14937-14937
Open Access | Times Cited: 67
Eva Kúdelová, Marek Smolár, Veronika Holubeková, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14937-14937
Open Access | Times Cited: 67
Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 32
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 32
Breast Cancer Genetics: Diagnostics and Treatment
Carmen Criscitiello, Chiara Corti
Genes (2022) Vol. 13, Iss. 9, pp. 1593-1593
Open Access | Times Cited: 32
Carmen Criscitiello, Chiara Corti
Genes (2022) Vol. 13, Iss. 9, pp. 1593-1593
Open Access | Times Cited: 32
Genetic behind breast cancer: Germline and somatic factors
Riya Sharma, Rahul Kumar Sharma, Prasad Khodke, et al.
Elsevier eBooks (2025), pp. 69-88
Closed Access
Riya Sharma, Rahul Kumar Sharma, Prasad Khodke, et al.
Elsevier eBooks (2025), pp. 69-88
Closed Access
Association of ESR1, HER1, and HER2 Polymorphisms with Breast Cancer Risk in the KP Population, A Case-Control Study
Najeeb Ullah Khan, Hamza Khan, Abdullah R. Alanzi, et al.
Journal of Mammary Gland Biology and Neoplasia (2025) Vol. 30, Iss. 1
Open Access
Najeeb Ullah Khan, Hamza Khan, Abdullah R. Alanzi, et al.
Journal of Mammary Gland Biology and Neoplasia (2025) Vol. 30, Iss. 1
Open Access
Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancer
Bhoomi Tarapara, Franky D. Shah
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Bhoomi Tarapara, Franky D. Shah
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Clinico-genomic Characterization ofATMand HRD in Pancreas Cancer: Application for Practice
Wungki Park, Catherine O’Connor, Chaitanya Bandlamudi, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 21, pp. 4782-4792
Open Access | Times Cited: 19
Wungki Park, Catherine O’Connor, Chaitanya Bandlamudi, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 21, pp. 4782-4792
Open Access | Times Cited: 19
ICEGAN: inverse covariance estimating generative adversarial network
Insoo Kim, Minhyeok Lee, Junhee Seok
Machine Learning Science and Technology (2023) Vol. 4, Iss. 2, pp. 025008-025008
Open Access | Times Cited: 12
Insoo Kim, Minhyeok Lee, Junhee Seok
Machine Learning Science and Technology (2023) Vol. 4, Iss. 2, pp. 025008-025008
Open Access | Times Cited: 12
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine
Roberto Piergentili, Enrico Marinelli, Gaspare Cucinella, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 2, pp. 16-16
Open Access | Times Cited: 4
Roberto Piergentili, Enrico Marinelli, Gaspare Cucinella, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 2, pp. 16-16
Open Access | Times Cited: 4
ATM in immunobiology: From lymphocyte development to cancer immunotherapy
Ji‐Hoon Lee
Translational Oncology (2025) Vol. 52, pp. 102268-102268
Open Access
Ji‐Hoon Lee
Translational Oncology (2025) Vol. 52, pp. 102268-102268
Open Access
The evolving landscape of genetic biomarkers for immunotherapy in primary and metastatic breast cancer
Liang Jin, Zijian Yang, Wei Tang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Liang Jin, Zijian Yang, Wei Tang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania
Claudiu Ioan Filip, Andreea Cătană, Enikő Kutasi, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 570-570
Open Access | Times Cited: 3
Claudiu Ioan Filip, Andreea Cătană, Enikő Kutasi, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 570-570
Open Access | Times Cited: 3
Germline rare variants in HER2-positive breast cancer predisposition: a systematic review and meta-analysis
Angélica Cerveira de Baumont, Nathan Araujo Cadore, Luana Giongo Pedrotti, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Angélica Cerveira de Baumont, Nathan Araujo Cadore, Luana Giongo Pedrotti, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies
Ji‐Hoon Lee
Cancer Treatment Reviews (2024) Vol. 129, pp. 102808-102808
Open Access | Times Cited: 3
Ji‐Hoon Lee
Cancer Treatment Reviews (2024) Vol. 129, pp. 102808-102808
Open Access | Times Cited: 3
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness
Elena Oropeza, Sinem Şeker, Sabrina Carrel, et al.
Science Advances (2023) Vol. 9, Iss. 26
Open Access | Times Cited: 8
Elena Oropeza, Sinem Şeker, Sabrina Carrel, et al.
Science Advances (2023) Vol. 9, Iss. 26
Open Access | Times Cited: 8
Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan
Hilal Ahmad, Asif Ali, Roshan Ali, et al.
Neoplasia (2024) Vol. 51, pp. 100989-100989
Open Access | Times Cited: 2
Hilal Ahmad, Asif Ali, Roshan Ali, et al.
Neoplasia (2024) Vol. 51, pp. 100989-100989
Open Access | Times Cited: 2
Targeted sequencing for hereditary breast and ovarian cancer in BRCA1/2-negative families reveals complex genetic architecture and phenocopies
Jocelyn N Plowman, Evanjalina J Matoy, Lavanya V. Uppala, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 3, pp. 100306-100306
Open Access | Times Cited: 2
Jocelyn N Plowman, Evanjalina J Matoy, Lavanya V. Uppala, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 3, pp. 100306-100306
Open Access | Times Cited: 2
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review
Tara M. Hosseini, Soo J. Park, Theresa Guo
Cancers (2024) Vol. 16, Iss. 16, pp. 2904-2904
Open Access | Times Cited: 2
Tara M. Hosseini, Soo J. Park, Theresa Guo
Cancers (2024) Vol. 16, Iss. 16, pp. 2904-2904
Open Access | Times Cited: 2
Implementing the Risk Stratification and Clinical Management of Breast Cancer Families Using Polygenic Risk Score Evaluation: A Pilot Study
Barbara Rizzacasa, Vanessa Nicolì, Chantal Tancredi, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1034-1034
Open Access | Times Cited: 2
Barbara Rizzacasa, Vanessa Nicolì, Chantal Tancredi, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1034-1034
Open Access | Times Cited: 2
Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer
Tapan Behl, Ankush Kumar, Vishakha Vishakha, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126595-126595
Closed Access | Times Cited: 6
Tapan Behl, Ankush Kumar, Vishakha Vishakha, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126595-126595
Closed Access | Times Cited: 6
Value of Conventional MRI, DCE-MRI, and DWI-MRI in the Discrimination of Metastatic from Non-Metastatic Lymph Nodes in Rectal Cancer: A Systematic Review and Meta-Analysis Study
Arvin Arian, Hayder Jasim Taher, Hayder Suhail Najm Alareer, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 2, pp. 401-410
Open Access | Times Cited: 5
Arvin Arian, Hayder Jasim Taher, Hayder Suhail Najm Alareer, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 2, pp. 401-410
Open Access | Times Cited: 5
Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity
Gulnur Zhunussova, Nazgul Omarbayeva, Dilyara Kaidarova, et al.
Oncotarget (2023) Vol. 14, Iss. 1, pp. 860-877
Open Access | Times Cited: 4
Gulnur Zhunussova, Nazgul Omarbayeva, Dilyara Kaidarova, et al.
Oncotarget (2023) Vol. 14, Iss. 1, pp. 860-877
Open Access | Times Cited: 4
Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk
Ying Wang, Yalan Sun, Mingjuan Tan, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 5, pp. 219-231
Closed Access | Times Cited: 1
Ying Wang, Yalan Sun, Mingjuan Tan, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 5, pp. 219-231
Closed Access | Times Cited: 1